{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:38:37Z","timestamp":1794616717392,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hangzhou Health and Health Commission","award":["A20230658"],"award-info":[{"award-number":["A20230658"]}]},{"name":"Provincial Central Management Bureau Heritage Innovation Talent Project","award":["2024ZR121"],"award-info":[{"award-number":["2024ZR121"]}]},{"name":"Hangzhou Medical Key Cultivation Discipline","award":["2020SJZDXK13"],"award-info":[{"award-number":["2020SJZDXK13"]}]},{"name":"Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project","award":["2021ZA107"],"award-info":[{"award-number":["2021ZA107"]}]},{"name":"Clinical Research Project of the China Association of Chinese Medicine","award":["ZA_CACM_2024002"],"award-info":[{"award-number":["ZA_CACM_2024002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03655-y","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T10:04:40Z","timestamp":1738836280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Machine learning-based plasma metabolomics for improved cirrhosis risk stratification"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1917-4890","authenticated-orcid":false,"given":"Jingru","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8211-1956","authenticated-orcid":false,"given":"Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"issue":"3","key":"3655_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","volume":"5","author":"The global","year":"2020","unstructured":"The global. Regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(3):245\u201366.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"3655_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/1751-2980.13294","volume":"25","author":"Chinese consensus on","year":"2024","unstructured":"Chinese consensus on. The management of liver cirrhosis. J Dig Dis. 2024;25(6):332\u201352.","journal-title":"J Dig Dis"},{"issue":"9055","key":"3655_CR3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","volume":"349","author":"T Poynard","year":"1997","unstructured":"Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349(9055):825\u201332.","journal-title":"Lancet"},{"issue":"2","key":"3655_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jhep.2022.02.022","volume":"77","author":"H Innes","year":"2022","unstructured":"Innes H, Morling JR, Buch S, Hamill V, Stickel F, Guha IN. Performance of routine risk scores for predicting cirrhosis-related morbidity in the community. J Hepatol. 2022;77(2):365\u201376.","journal-title":"J Hepatol"},{"issue":"10","key":"3655_CR5","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.cgh.2019.12.041","volume":"18","author":"C Delac\u00f4te","year":"2020","unstructured":"Delac\u00f4te C, Bauvin P, Louvet A, Dautrecque F, Ntandja Wandji LC, Lassailly G, Voican C, Perlemuter G, Naveau S, Mathurin P, et al. A model to identify heavy drinkers at high risk for liver disease progression. Clin Gastroenterol Hepatol. 2020;18(10):2315\u2013e23232316.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"3655_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/infdis\/jiaa330","volume":"223","author":"AK Le","year":"2021","unstructured":"Le AK, Yang HI, Yeh ML, Jin M, Trinh HN, Henry L, Liu A, Zhang JQ, Li J, Wong C, et al. Development and validation of a risk score for liver cirrhosis prediction in untreated and treated chronic hepatitis B. J Infect Dis. 2021;223(1):139\u201346.","journal-title":"J Infect Dis"},{"issue":"6","key":"3655_CR7","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1053\/j.gastro.2008.03.001","volume":"134","author":"DS Manning","year":"2008","unstructured":"Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology. 2008;134(6):1670\u201381.","journal-title":"Gastroenterology"},{"issue":"1","key":"3655_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/HEP.0000000000000707","volume":"80","author":"F \u00c5berg","year":"2024","unstructured":"\u00c5berg F, Asteljoki J, M\u00e4nnist\u00f6 V, Luukkonen PK. Combined use of the CLivD score and FIB-4 for prediction of liver-related outcomes in the population. Hepatology. 2024;80(1):163\u201372.","journal-title":"Hepatology"},{"issue":"7","key":"3655_CR9","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","volume":"36","author":"P Horn","year":"2024","unstructured":"Horn P, Tacke F. Metabolic reprogramming in liver fibrosis. Cell Metab. 2024;36(7):1439\u201355.","journal-title":"Cell Metab"},{"key":"3655_CR10","doi-asserted-by":"publisher","first-page":"102336","DOI":"10.1016\/j.ceca.2020.102336","volume":"94","author":"B Morio","year":"2021","unstructured":"Morio B, Panthu B, Bassot A, Rieusset J. Role of mitochondria in liver metabolic health and diseases. Cell Calcium. 2021;94:102336.","journal-title":"Cell Calcium"},{"issue":"1","key":"3655_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/j.ajkd.2023.05.014","volume":"83","author":"TT Geng","year":"2024","unstructured":"Geng TT, Chen JX, Lu Q, Wang PL, Xia PF, Zhu K, Li Y, Guo KQ, Yang K, Liao YF, et al. Nuclear magnetic resonance-based metabolomics and risk of CKD. Am J Kidney Dis. 2024;83(1):9\u201317.","journal-title":"Am J Kidney Dis"},{"key":"3655_CR12","doi-asserted-by":"publisher","unstructured":"Gilgenkrantz H, Paradis V, Lotersztajn S. Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma. Hepatology. 2023. https:\/\/doi.org\/10.1097\/HEP.00000000000004790.1097\/HEP.0000000000000479","DOI":"10.1097\/HEP.00000000000004790.1097\/HEP.0000000000000479"},{"key":"3655_CR13","doi-asserted-by":"crossref","unstructured":"Beyo\u011flu D, Popov YV, Idle JR. The metabolomic footprint of liver fibrosis. Cells. 2024;13(16).","DOI":"10.3390\/cells13161333"},{"issue":"3","key":"3655_CR14","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"key":"3655_CR15","doi-asserted-by":"crossref","unstructured":"Guo C, Liu Z, Fan H, Wang H, Zhang X, Zhao S, Li Y, Han X, Wang T, Chen X et al. Machine-learning-based plasma metabolomic profiles for predicting long-term complications of cirrhosis. Hepatology. 2024.","DOI":"10.1097\/HEP.0000000000000879"},{"issue":"7726","key":"3655_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, Motyer A, Vukcevic D, Delaneau O, O\u2019Connell J, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562(7726):203\u20139.","journal-title":"Nature"},{"issue":"11","key":"3655_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1167\/iovs.64.11.11","volume":"64","author":"LR Pasquale","year":"2023","unstructured":"Pasquale LR, Khawaja AP, Wiggs JL, Kim J, Hysi P, Elze T, Lasky-Su J, Kang JH, Zeleznik O. Metabolite and lipid biomarkers associated with intraocular pressure and inner retinal morphology: 1H NMR spectroscopy results from the UK Biobank. Invest Ophthalmol Vis Sci. 2023;64(11):11.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3655_CR18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","volume":"165","author":"S Man","year":"2023","unstructured":"Man S, Deng Y, Ma Y, Fu J, Bao H, Yu C, Lv J, Liu H, Wang B, Li L. Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: a nationwide study with 5.7 million adults in China. Gastroenterology. 2023;165(4):1025\u201340.","journal-title":"Gastroenterology"},{"key":"3655_CR19","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1136\/bmj.p2598","volume":"383","author":"C Carmona","year":"2023","unstructured":"Carmona C, Claxton L, O\u2019Brien A, Hebditch V. Cirrhosis in over 16s: assessment and management-updated summary of NICE guidance. BMJ. 2023;383:2598.","journal-title":"BMJ"},{"issue":"6","key":"3655_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, Loomba R. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388\u201398.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3655_CR21","doi-asserted-by":"publisher","first-page":"155789","DOI":"10.1016\/j.metabol.2024.155789","volume":"152","author":"E Han","year":"2024","unstructured":"Han E, Lee BW, Kang ES, Cha BS, Ahn SH, Lee YH, Kim SU. Mortality in metabolic dysfunction-associated steatotic liver disease: a nationwide population-based cohort study. Metabolism. 2024;152:155789.","journal-title":"Metabolism"},{"key":"3655_CR22","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3389\/fonc.2020.01210","volume":"10","author":"Q Chen","year":"2020","unstructured":"Chen Q, Li F, Gao Y, Xu G, Liang L, Xu J. Identification of energy metabolism genes for the prediction of survival in hepatocellular carcinoma. Front Oncol. 2020;10:1210.","journal-title":"Front Oncol"},{"issue":"7","key":"3655_CR23","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"key":"3655_CR24","doi-asserted-by":"crossref","unstructured":"Park JG, Tak WY, Park SY, Kweon YO, Chung WJ, Jang BK, Bae SH, Lee HJ, Jang JY, Suk KT et al. Effects of branched-chain amino acid (BCAA) supplementation on the progression of advanced liver disease: a Korean nationwide, multicenter, prospective, observational, cohort study. Nutrients. 2020;12(5).","DOI":"10.3390\/nu12051429"},{"issue":"1","key":"3655_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11064-019-02743-2","volume":"45","author":"T Shulyatnikova","year":"2020","unstructured":"Shulyatnikova T, Verkhratsky A. Astroglia in sepsis associated encephalopathy. Neurochem Res. 2020;45(1):83\u201399.","journal-title":"Neurochem Res"},{"key":"3655_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2019.11.009","volume":"74","author":"K Katayama","year":"2020","unstructured":"Katayama K. Zinc and protein metabolism in chronic liver diseases. Nutr Res. 2020;74:1\u20139.","journal-title":"Nutr Res"},{"issue":"3","key":"3655_CR27","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/hep.24412","volume":"54","author":"T Kawaguchi","year":"2011","unstructured":"Kawaguchi T, Izumi N, Charlton MR, Sata M. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology. 2011;54(3):1063\u201370.","journal-title":"Hepatology"},{"issue":"6","key":"3655_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.21037\/atm.2020.02.184","volume":"8","author":"N M\u00e9ndez-S\u00e1nchez","year":"2020","unstructured":"M\u00e9ndez-S\u00e1nchez N, Valencia-Rodr\u00edguez A, Coronel-Castillo C, Vera-Barajas A, Contreras-Carmona J, Ponciano-Rodr\u00edguez G, Zamora-Vald\u00e9s D. The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis. Annals Translational Med. 2020;8(6):400.","journal-title":"Annals Translational Med"},{"key":"3655_CR29","doi-asserted-by":"crossref","unstructured":"Chang ML, Yang SS. Metabolic signature of hepatic fibrosis: from individual pathways to systems biology. Cells. 2019;8(11).","DOI":"10.3390\/cells8111423"},{"issue":"2","key":"3655_CR30","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.23719","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology. 2010;52(2):774\u201388.","journal-title":"Hepatology"},{"issue":"5","key":"3655_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2174\/1573405617666210712141600","volume":"22","author":"MA Barrios-Maya","year":"2022","unstructured":"Barrios-Maya MA, Ruiz-Ram\u00edrez A, El-Hafidi M. Endogenous liver protections against lipotoxicity and oxidative stress to avoid the progression of non-alcoholic fatty liver to more serious disease. Curr Mol Med. 2022;22(5):401\u201320.","journal-title":"Curr Mol Med"},{"issue":"1","key":"3655_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jcmgh.2014.11.005","volume":"1","author":"P Hirsova","year":"2015","unstructured":"Hirsova P, Gores GJ. Death receptor-mediated cell death and proinflammatory signaling in nonalcoholic steatohepatitis. Cell Mol Gastroenterol Hepatol. 2015;1(1):17\u201327.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3655_CR33","doi-asserted-by":"crossref","unstructured":"Ramanathan R, Ali AH, Ibdah JA. Mitochondrial dysfunction plays central role in nonalcoholic fatty liver disease. Int J Mol Sci. 2022;23(13).","DOI":"10.3390\/ijms23137280"},{"issue":"4","key":"3655_CR34","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","volume":"114","author":"CP Day","year":"1998","unstructured":"Day CP, James OF. Steatohepatitis: a tale of two hits? Gastroenterology. 1998;114(4):842\u20135.","journal-title":"Gastroenterology"},{"key":"3655_CR35","doi-asserted-by":"crossref","unstructured":"Song M, Sun Y, Tian J, He W, Xu G, Jing Z, Li W. Silencing retinoid X receptor alpha expression enhances early-stage Hepatitis B virus infection in cell cultures. J Virol. 2018;92(8).","DOI":"10.1128\/JVI.01771-17"},{"issue":"10","key":"3655_CR36","first-page":"6462","volume":"11","author":"Y An","year":"2019","unstructured":"An Y, Guan Y, Xu Y, Han Y, Wu C, Bao C, Zhou B, Wang H, Zhang M, Liu W, et al. The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinoma. Am J Transl Res. 2019;11(10):6462\u201374.","journal-title":"Am J Transl Res"},{"issue":"4","key":"3655_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3350\/cmh.2012.18.4.411","volume":"18","author":"PJ Park","year":"2012","unstructured":"Park PJ, Hwang S, Choi YI, Yu YD, Park GC, Jung SW, Yoon SY, Song GW, Ha TY, Lee SG. Liver transplantation for acute-on-chronic liver failure from erythropoietic protoporphyria. Clin Mol Hepatol. 2012;18(4):411\u20135.","journal-title":"Clin Mol Hepatol"},{"issue":"8","key":"3655_CR38","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/liv.13076","volume":"36","author":"ZG Jiang","year":"2016","unstructured":"Jiang ZG, Tapper EB, Connelly MA, Pimentel CF, Feldbr\u00fcgge L, Kim M, Krawczyk S, Afdhal N, Robson SC, Herman MA, et al. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease. Liver Int. 2016;36(8):1213\u201320.","journal-title":"Liver Int"},{"issue":"9","key":"3655_CR39","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s005350070045","volume":"35","author":"J Wu","year":"2000","unstructured":"Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol. 2000;35(9):665\u201372.","journal-title":"J Gastroenterol"},{"issue":"9","key":"3655_CR40","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","volume":"122","author":"RW McGarrah","year":"2018","unstructured":"McGarrah RW, Crown SB, Zhang GF, Shah SH, Newgard CB. Cardiovascular metabolomics. Circ Res. 2018;122(9):1238\u201358.","journal-title":"Circ Res"},{"key":"3655_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fphar.2020.00066","volume":"11","author":"T Wei","year":"2020","unstructured":"Wei T, Shu Q, Ning J, Wang S, Li C, Zhao L, Zheng H, Gao H. The protective effect of basic fibroblast growth factor on diabetic nephropathy through remodeling metabolic phenotype and suppressing oxidative stress in mice. Front Pharmacol. 2020;11:66.","journal-title":"Front Pharmacol"},{"issue":"5","key":"3655_CR42","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.cell.2019.07.048","volume":"178","author":"CW Cheng","year":"2019","unstructured":"Cheng CW, Biton M, Haber AL, Gunduz N, Eng G, Gaynor LT, Tripathi S, Calibasi-Kocal G, Rickelt S, Butty VL, et al. Ketone body signaling mediates intestinal stem cell homeostasis and adaptation to diet. Cell. 2019;178(5):1115\u2013e11311115.","journal-title":"Cell"},{"key":"3655_CR43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3389\/fphys.2019.00856","volume":"10","author":"E Parvaresh Rizi","year":"2019","unstructured":"Parvaresh Rizi E, Baig S, Loh TP, Toh SA, Khoo CM, Tai ES. Two-hour postprandial lipoprotein particle concentration differs between lean and obese individuals. Front Physiol. 2019;10:856.","journal-title":"Front Physiol"},{"issue":"2","key":"3655_CR44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cell.2014.09.035","volume":"159","author":"MM Yore","year":"2014","unstructured":"Yore MM, Syed I, Moraes-Vieira PM, Zhang T, Herman MA, Homan EA, Patel RT, Lee J, Chen S, Peroni OD, et al. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell. 2014;159(2):318\u201332.","journal-title":"Cell"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03655-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03655-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03655-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T10:05:04Z","timestamp":1738836304000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03655-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3655"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03655-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"19 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was provided by the North West Multi-Center Research Ethics Committee (REC reference number: 21\/NW\/0157). All participants provided informed consent prior to inclusion in the study. The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki, and the use of secondary data from the UK Biobank was approved by the committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Clinical trial number: not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}],"article-number":"61"}}